Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2012

View Archived Issues

FANG cancer vaccine evaluated in phase I trial

JVRS-100 improves H5N1 vaccine immunogenicity

Novel muscarinic acetylcholine M1 receptor modulators disclosed

U.S. researchers prepare new vaccines

Novel protein kinase inhibitors disclosed by SBI Biotech and CrystalGenomics

NeuroSearch patents novel monoamine neurotransmitter reuptake inhibitors

Roche presents novel AMPK activators

University of Illinois forms new start-up company for cancer products

Medicure to commence SAVI-PCI trial of Aggrastat

Immune Pharmaceuticals granted funds by Israel's Office of the Chief Scientist

Study identifies potential biomarkers of Huntington's disease progression

Transcend-trastuzumab conjugate BT-2111 program advances

AMAG Pharmaceuticals completes enrollment in Feraheme trial

New antibodies designed by Novo Nordisk for hemophilia

Allos Therapeutics requests reexamination of CHMP opinion on Folotyn

FDA approves first treatment for advanced BCC

Health Canada accepts CIP-Isotretinoin submission for review

Jentadueto approved in U.S.

Servier and Monash University establish GPCR collaboration

Domain Therapeutics receives award to develop therapeutics for Parkinson's disease

Orexo ends collaboration with Janssen

Takeda returns Posidur rights to Durect

ATS-907 enters clinical development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...